Lbl Biotech
LBL Biotech is developing a combination therapy treatment targeting pancreatic cancer. Our proprietary technology combines IL-20 antibody with an immune checkpoint PD-1 antibody to attenuate tumors and has delivered excellent efficacy in treating liver cancer, breast cancer, cancer-induced cachexia (CAC), chemotherapy-induced neurological disease, and spinal cord injuries.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1
11 to 50 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Lbl Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Lbl Biotech
1 distinct titles indexed · top 1 shown.
- 1founder & chief scientific officer
Sign up to unlock all 1 contacts at Lbl Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Lbl Biotech
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.